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Abstract
Intra-aortic balloon pumps (IABP) are commonly used in the setting of an acute myocardial
infarction that is complicated by cardiogenic shock or mechanical complications such as
a ventricular septal defect or papillary muscle rupture. IABP has also been shown to be useful
in patients with refractory and hemodynamically unstable ventricular arrhythmias and refrac-
tory post-myocardial infarction angina.
We report a case in which IABP was used in a patient with dilated cardiomyopathy and
normal coronary arteries, who presented with persistent, recurrent and refractory ventricular
tachycardia. His ventricular tachycardia settled immediately with the use of IABP therapy. He
subsequently had an implantable defibrillator.
The use of IABP is associated with favorable changes in the left ventricular wall tension and
reduction in afterload, which could reduce the excitability of the myocardium, thus making it
less prone to arrhythmias. The use of IABP is relatively safe and should be considered in
patients with refractory ventricular arrhythmias, even if it is not associated with ischemia.
(Cardiol J 2010; 17, 4: 401–403)
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Introduction
Ventricular arrhythmias either ventricular
tachycardia (VT) or ventricular fibrillation (VF) are
a common complication seen in patients with im-
paired ventricular function [1]. VF is associated with
hemodynamic compromise and requires prompt
electric cardioversion. VT, on the other hand, may
be associated with a stable blood pressure. They are
often due to re-entry in a region of previous myo-
cardial infarction or ventricular scar. In patients with
idiopathic dilated cardiomyopathy, they could result
from abnormal circuits and abnormal action poten-
tials due to stretch, damage and fibrosis of the myo-
cardium [2, 3]. If the VT repeatedly recurs and
persists for more than half of a 24 hour period, de-
spite repeated attempts to terminate the arrhyth-
mia, it is designated ‘incessant’. In these patients,
anti-arrhythmic agents can be tried in the first in-
stance. If, however, they fail, urgent electric cardio-
version is indicated.
Occasionally, VT fails to respond to repeated
electric cardioversion and anti-arrhythmic agents.
Ischemia is a common cause of incessant ventricular
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arrhythmias and prompt relief of ischemia by per-
cutaneous coronary intervention helps to relieve
the arrhythmia. In conditions where relief of
ischemia may not be possible (e.g. where lesions
are not amenable to percutaneous coronary inter-
vention), or if there is no ischemia, unconventional
methods such as overdrive pacing and the use of
an intra-aortic balloon pump may be attempted.
Here, we report a case where the VT was not of
ischemic origin, and was resistant to various anti-
arrhythmic agents, responding only after the intro-
duction of an intra-aortic balloon pump (IABP).
Case report
A 52 year-old male with a history of non-insulin
dependent diabetes was admitted feeling unwell with
increasing shortness of breath. His presenting
electrocardiogram showed VT (rate of around 270–
–300, monomorphic and with an abnormal leftward
axis of –75) (Fig. 1) and he was clinically in pulmonary
edema which was confirmed radiologically. Arterial
blood gases revealed type 2 respiratory failure with
acidosis (pH: 7.20, pCO2: 9.45 kPa [normal 4.5–
–6 kPa]; pO2: 9.06 kPa [normal 10–13 kPa]; HCO3:
16.4 mmol/L [normal 20–24 mmoL/l]).
The VT was initially managed with intravenous
lignocaine followed by intravenous amiodarone but
these were not successful. In view of the respira-
tory failure and acidosis, he was ventilated and
managed in the intensive therapy unit (ITU). The
VT finally responded to electrical cardioversion
(150 J of biphasic current) with the restoration of
sinus rhythm and the amiodarone infusion was
continued. On the day of admission, he had recur-
rent bouts of VT, each successfully reverting to
sinus rhythm with a single shock of 150 J biphasic
current.
His bedside echocardiogram revealed a dilat-
ed left ventricle (LV) with global hypokinesis and
severely impaired LV systolic function. In ITU, he
had recurrent episodes of VT (similar morphology
to the admission VT) whilst on the amiodarone in-
fusion and despite correction of his electrolytes,
requiring repeated electrical cardioversion. He had
a total of seven shocks within 12 hours of the first
day of admission (two were an hour apart; then he
had three within one hour; two hours later he had
another two shocks) and a further two shocks on
the second day. At first, the VT did not cause he-
modynamic compromise (he had maintained a blood
pressure of above 120/80 mm Hg at most times) and
he never lost his cardiac output or required cardio-
pulmonary resuscitation. However, the later epi-
sodes of VT made him hypotensive and he was com-
menced on ionotropic support.
Figure 1. Presenting electrocardiogram showing ventricular tachycardia.
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He had raised cardiac enzymes (troponin T was
elevated at 0.19 µg/L [normal < 0.01 µg/L]). He
underwent coronary angiography to rule out under-
lying myocardial ischemia as the cause of the VT,
but it revealed normal coronary arteries with a glo-
bally dilated and poorly contracting left ventricle.
An IABP was inserted to improve hemodynamics.
Immediately prior to the IABP insertion, his blood
pressure was 81/54 mm Hg. Once the IABP was in-
serted, he had no further VT. His blood pressure
improved and on 1:1 augmentation he maintained
a blood pressure of around 120/70 mm Hg. He was
subsequently weaned off the ionotropes as well as
the IABP. He subsequently had an implantable car-
dioverter defibrillator implanted and was discharged
home in a couple of days with no further VT.
Discussion
Intra-aortic balloon counter pulsation therapy
has been used to treat refractory ventricular ar-
rhythmias in patients with coronary artery disease
awaiting revascularisation, and is a class IIa recom-
mended indication for  use by the American Heart
Association/American College of Cardiology guide-
lines [4]. However, there are not many reports on
the use of this therapy in patients with normal cor-
onary arteries. Fotopoulos et al. [5] used IABP in
21 consecutive patients with refractory ventricular
arrhythmias. Eighteen of these patients had signi-
ficant coronary artery disease. Of the remaining
three, two had idiopathic dilated cardiomyopathy
and one had amyloidosis. The use of IABP stabilized
18 out of the 21 patients. Complete abolition of ar-
rhythmia was reported in 14 patients, while four
other patients had significant reduction in ventricu-
lar arrhythmias. Two out of the three patients with
normal coronary arteries survived and their ar-
rhythmia responded to treatment with IABP. These
two patients had an IABP support period of 3–
–9 days, while our patient’s ventricular arrhythmia
was well controlled immediately after IABP
insertion, and his IABP was withdrawn within two
days of insertion.
In patients with ischemic heart disease, the
benefit of IABP in controlling VT could be in im-
proving coronary blood flow and thereby reducing
ischemia. However, in patients with normal coro-
nary arteries, the mechanism of action is less clear.
It has been suggested that using IABP reduces the
adrenergic drive which is arrhythmogenic and
thereby reduces the vulnerability of the myocar-
dium to arrhythmias. IABP causes systolic left ven-
tricular offloading and this reduces myocardial wall
tension and oxygen demand which could improve
oxygenation of the myocardium.
It is possible that the mechanical effect of the
IABP has a direct effect in controlling arrhythmias.
Animal studies [6] have demonstrated that with
progressive increase in the afterload, there is an
increase in ventricular ectopy and tachycardia. Simi-
larly, stretching of normal cardiac tissue results in
a reduction of action potential duration and an in-
crease in spontaneous depolarization [7]. The use
of IABP reduces LV afterload, and thereby reduces
myocardial stretching and distension, and could
thereby make the myocardium less irritable.
Our patient had refractory VT of a non-ische-
mic aetiology that responded promptly to IABP use.
IABP is a relatively safe procedure [8]. We feel that
its use should be considered more frequently in the
setting of recurrent and intractable ventricular ar-
rhythmias with or without hemodynamic compro-
mise unrelated to acute ischemic heart disease.
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